Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects

M. Milella, C. M. Precupanu, C. Gregorj, M. R. Ricciardi, M. T. Petrucci, S. M. Kornblau, A. Tafuri, M. Andreeff

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences